Market research
6BX.F Relevium Technologies Inc
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 5M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 2.66
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- ISIN
- CA75942W1023
- Market cap
- 5M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 2.66
About
About Relevium Technologies Inc
Relevium Technologies Inc. engages in the identification, evaluation, acquisition, and operation of brands and businesses in the health and wellness markets with a focus on e-commerce. The company markets dietary supplements, nutraceuticals, sports nutrition products, and cosmeceuticals primarily through its Bioganix brand portfolio online; dietary supplements under the LeefyLyfe brand name; and skin care products under the Push & Pull System brand. It also provides Relevium Senior, a geriatric brand targeting inflammatory conditions, including joints, heart, and brain; and Relevium Kids, a pediatric brand of nutraceuticals and oral nutritional supplements. The company was formerly known as BIOflex Technologies Inc. and changed its name to Relevium Technologies Inc. in December 2015. Relevium Technologies Inc. is headquartered in Montreal, Canada.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 6BX.F discussion.
5 years, 5 months ago
Relevium Technologies Inc is currently in a long term downtrend where the price is trading 34.4% below its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.0.
Relevium Technologies Inc's total revenue sank by 87.7% to $139K since the same quarter in the previous year.
Its net income has dropped by 20.2% to $-531K since the same quarter in the previous year.
Finally, its free cash flow fell by 4563.4% to $-10M since the same quarter in the previous year.
Based on the above factors, Relevium Technologies Inc gets an overall score of 1/5.